Related Experiment Video
Updated: May 15, 2025
05:31
Author Spotlight: Modeling an Aspect of Preeclampsia in Female Mice Using Hypoxic Human Placenta-Derived Small Extracellular Vesicles
Published on: January 26, 2024
717
Risk factors associated with progression from pre-eclampsia to eclampsia: A prospective cohort study and
Annettee Nakimuli1, Brittany A Jasper2, Sarah Nakubulwa1
1Department of Obstetrics and Gynaecology, Makerere University and Mulago National Referral Hospital, Kampala, Uganda.
Acta Obstetricia Et Gynecologica Scandinavica
|May 14, 2025
Summary
Identifying risk factors for eclampsia progression in pre-eclampsia is crucial, especially in low-resource settings. Socioeconomic factors and younger maternal age, not just clinical severity, predict eclampsia risk.
Area of Science:
- Obstetrics and Gynecology
- Maternal Health
- Public Health
Background:
- Eclampsia is a severe, life-threatening complication of pre-eclampsia.
- Current methods for identifying high-risk pre-eclampsia patients are unreliable, particularly in resource-limited settings.
- Predicting eclampsia progression is vital for prioritizing care and timely interventions.
Purpose of the Study:
- To identify risk factors for the progression of pre-eclampsia to eclampsia.
- To validate these findings in diverse populations, including low- and middle-income settings.
- To inform targeted strategies for preventing eclampsia.
Main Methods:
- Prospective cohort study in urban Uganda (2011-2016) with pre-eclampsia patients.
- Multivariable logistic regression to identify predictive risk factors for eclampsia.
- Validation using population-wide hospital data from Ecuador (2021-2023).
Main Results:
- In Uganda, nulliparity, Baganda ethnicity, and paternal unemployment were associated with eclampsia progression.
- Younger maternal age showed a trend toward increased risk in both Uganda and Ecuador.
- Pre-eclampsia severity and antenatal visit frequency did not predict progression.
Conclusions:
- Eclampsia risk is influenced by socioeconomic factors and maternal age, beyond clinical pre-eclampsia severity.
- A targeted approach focusing on young women with socioeconomic vulnerabilities can optimize resource allocation.
- This strategy aims to mitigate risks associated with severe hypertensive disorders in pregnancy.
Related Concept Videos
01:20Pathophysiology of Diabetes
818
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
818
01:33Hormonal Regulation
32.7K
The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.
32.7K
01:28Factors affecting Blood pressure
2.8K
Several physiological and lifestyle factors influence blood pressure (BP). Understanding these factors is crucial as they are significant in patient education and blood pressure management.
Physiological Factors:
Physiological Factors:
2.8K
01:07Teratogenicity
2.3K
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
2.3K
01:22Diabetes Mellitus: Type 2 and Gestational
2.1K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.1K
01:29Factors Affecting Protein-Drug Binding: Patient-Related Factors
31
Protein-drug binding, a pivotal aspect of pharmacokinetics, is subject to considerable variability influenced by an array of patient-related factors. The intricate interplay of age, individual differences, and pathological conditions significantly impact the binding dynamics and subsequent pharmacological effects.
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...
31